Redefining Cancer Treatment With Personalized Medicine and Early Intervention – Geoffrey Moorer, MD
Trends in the treatment for patients with cancer are shifting towards earlier intervention, with effective therapies like immunotherapy moving into neoadjuvant stages for improved outcomes. However, Geoffrey D. Moorer, MD, believes that challenges remain in ensuring wider access to sequencing and overcoming data complexity. While the future holds immense potential for artificial intelligence to revolutionize […]
Virginia Cancer Specialists Physicians Named to Northern Virginia Magazine’s 2024 Top Doctors List
Virginia Cancer Specialists is proud to announce our physicians that have been named Northern Virginia Magazine’s 2024 Top Doctors. Top Doctors honorees are chosen through a selective, unbiased process. Congratulations to the following physicians for being honored in 2024: Stephanie Akbari, MD, FACS Ivan Aksentijevich, MD Christina Brzezniak, DO Daniel Chong, MD Robert Christie, […]
Understanding the Role of Palliative Care in Cancer Treatment – Muhammad Siddiqui, MD
Role of Palliative Care in Cancer Treatment In an interview with Targeted Oncology, Muhammad Siddiqui, MD, explained the role that palliative medicine plays in a cancer treatment plan and how oncologists and palliative care physicians can work together in patients’ best interests. Palliative care physicians work to improve the quality-of-life of patients with serious or […]
Revolutionizing Breast Cancer Care: Insights and Recommendations from a Pivotal Germline Mutation Testing Study
Dr. Patricia Rodriguez of Virginia Cancer Specialists, is a co-author of the joint guideline paper issued by the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) that aims to provide evidence-based recommendations for healthcare professionals dealing with precision care for breast cancer patients. The main goal of this paper was […]
Woodbridge Office Move – January 29th!
Exciting News! Our Woodbridge Office is relocating to a New Suite on January 29th! Join us in welcoming our providers, staff and patients to its new, state-of-the-art location. Mark your calendars for January 29th as we embark on this new chapter of providing comprehensive and compassionate cancer care.
Brentuximab Vedotin: A Promising Frontline Therapy for Older Hodgkin Lymphoma Patients
A recent study published by Dr. Dipti Patel-Donnelly, of Virginia Cancer Specialists and colleagues has shed light on a groundbreaking approach in the treatment of advanced-stage classical Hodgkin lymphoma (cHL) in older patients. This noncomparative phase 2 study, detailed in the research article here, explores the efficacy of brentuximab vedotin (BV) in combination with dacarbazine […]